Mereo BioPharma
Mereo BioPharma is a clinical-stage biopharmaceutical company focused on developing therapies for rare diseases. Founded in 2015, the company works on drug development for patients with limited treatment options.
- Setrusumab
- Alvelestat
- Etigilimab
- Acumapimod
- Leflutrozole
- Navicixizumab
Locations
Company Details
Mereo BioPharma is operated by Mereo Biopharma Group Plc and is a Active company incorporated on 10 March 2015 with the registered office located in London, Greater London. Mereo Biopharma Group Plc was registered 10 years ago.
Status
Active
Size
Unreported
Directors
11
Age
10 years old
Employees
34
Turnover
Unreported
Total Assets
£72.91M
Cash in Bank
£55.64M
Total Liabilities
-£13.34M
Teams
27
7
4
4
1
1
1
Vice President, Head Of Quality • Joined Feb 2021
Vice President, Head Of HR • Joined Jan 2023
Vice President, Head Of Medical Affairs • Joined Jan 2025
Chief Executive Officer • Joined Jul 2015
Executive Director, Safety Scientist • Joined Jan 2025
Chief Financial Officer • Joined Jan 2021
Executive Assistant • Joined Jul 2015
Chief Patient Access & Commercial Planning • Joined Mar 2018
General Counsel And Business Development. Co-Founder • Joined Jul 2015
Manager, Admin • Joined Mar 2025
Chief Executive Officer • Joined Jul 2015
Senior Director, CMC • Joined Jan 2023
Head Of Patient Access • Joined Jun 2023
Senior Manager, Administration & HR Officer • Joined Jan 2022
Senior Director Clinical Operations • Joined Jan 2021
Management Accountant • Joined May 2022
Group Financial Controller • Joined Jun 2020
Chief Financial Officer • Joined Jan 2021
Finance Manager • Joined Jan 2023
Management Accountant • Joined May 2022
Group Financial Controller • Joined Jun 2020
Director, Clinical Science • Joined Nov 2021
Scientific Affairs Manager • Joined May 2024
Executive Assistant • Joined Jul 2015
Chief Financial Officer • Joined Jan 2021
Finance Manager • Joined Jan 2023
Management Accountant • Joined May 2022
Group Financial Controller • Joined Jun 2020
View 27 members